Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$45,903,917
+$6,320,520 QoQ
Shares Held
182,419
+0.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#388
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. ABBV ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,903,917 | 182,419 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $39,583,397 | 182,001 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $37,385,533 | 163,620 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $32,228,978 | 139,194 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $21,169,589 | 114,048 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $24,349,576 | 116,216 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $7,822,887 | 44,023 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,589,353 | 38,431 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,376,942 | 37,179 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $6,904,867 | 37,918 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,969,134 | 38,518 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $5,744,623 | 38,539 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $5,143,452 | 38,176 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,531,460 | 40,983 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $6,407,998 | 39,651 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $5,174,466 | 38,555 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,555,437 | 29,743 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,587,388 | 28,298 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $4,004,861 | 29,578 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,825,591 | 16,924 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,845,268 | 16,382 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,679,141 | 15,516 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,559,568 | 14,555 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,296,244 | 14,799 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,407,312 | 14,334 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $1,045,174 | 13,718 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||